Please provide your email address to receive an email when new articles are posted on . Patients with moderate or severe COPD experienced improvements with 3 mg of twice-daily ensifentrine. Study ...
Even though there's no cure for chronic obstructive pulmonary disease (COPD), there are many treatments that make you feel better, stay active, live longer, and just breathe easier. When you have ...
New research shows that the asthma drug benralizumab failed to decrease annual COPD exacerbation rates for patients with moderate to very severe COPD, a history of frequent moderate and/or severe ...
The clinical and survival benefit of home oxygen therapy, both LTOT and nocturnal oxygen therapy, for patients with COPD and moderate hypoxemia was evaluated in this meta-analysis. Home oxygen therapy ...
Budesonide/formoterol treatment decreased COPD exacerbations Budesonide/formoterol treatment decreased exacerbations in COPD after 3 months. Patients with moderate-to-very-severe chronic obstructive ...
Capsules and pills close up The use of regular, low-dose, oral sustained-release morphine for 4 weeks in patients with COPD and moderate to very severe breathlessness has been shown to improve disease ...
As chronic obstructive pulmonary disease (COPD) gets worse, it limits your airflow more and more. By stage II, your symptoms are usually no longer something you can just shrug off. They start to ...
Please provide your email address to receive an email when new articles are posted on . The addition of high-flow nasal cannula to long-term oxygen therapy may ...
* ASTRAZENECA - PT010 SHOWED STATISTICALLY SIGNIFICANT REDUCTION IN RATE OF MODERATE/SEVERE EXACERBATIONS IN PATIENTS WITH MODERATE TO VERY SEVERE COPD * ASTRAZENECA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback